Tenaya Therapeutics, Inc.
Total Awards:
2
Award Value:
$9,017,000
Institution type:
For profit
Short Name:
Tenaya Therapeutics, Inc.
Awards to the Institution
Program Type | Investigator | Grant Title | Award Value |
---|---|---|---|
Quest – Discovery Stage Research Projects | Karl N Doerner | Cardiac Reprogramming Gene Therapy for Post-Myocardial Infarction Heart Failure | $1,017,000 |
Clinical Trial Stage Projects | Dr. Matthew Pollman | Phase 1b Study of TN-401 in Adults with PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) | $8,000,000 |
Total: $9,017,000.00 |